FdaApplication
ANDA 215135
Identifiers
- fda_app_no: ANDA215135
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMS |
| application_type | ANDA |
| approval_date | 2022-03-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | 325MG;50MG;40MG | CAPSULE;ORAL |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | ACETAMINOPHEN; BUTALBITAL; CAFFEINE | 300MG;50MG;40MG | CAPSULE;ORAL |
2 products